Dermatology News

ORLANDO — Treating acne in transmasculine patients requires sensitivity to unique challenges, according to a speaker at the American Academy of Dermatology annual meeting.

It has been 5 years since the start of the COVID-19 pandemic, which forced many providers to embrace telehealth.

ORLANDO — A subset of patients treated with delgocitinib cream 20 mg/g for moderate to severe chronic hand eczema achieved a “super-response,” by week 16, according to a presenter at the American Academy of Dermatology Annual Meeting.

Newly released data from the phase 3 STOP-HS clinical trial program reveal positive results in hidradenitis suppurativa from povorcitinib treatment, Incyte announced in a press release.

ORLANDO — Twice-daily deucravacitinib 3 mg and 6 mg significantly improved cutaneous lupus erythematosus activity by week 16, according to a presenter at the American Academy of Dermatology Annual Meeting.

Senators questioned Mehmet Oz, MD, MBA, on Medicaid budget cuts, nursing shortages and his prior claims about miracle drugs during a committee hearing to be the next administrator of CMS.

ORLANDO — Treatment-experienced patients with moderate to severe atopic dermatitis attained higher efficacy rates on rocatinlimab compared with placebo, according to a presenter at the American Academy of Dermatology Annual Meeting

Investing in bonds may seem boring and not sexy like buying individual stocks, but bonds help provide diversification and stability to one’s portfolio.

The FDA released results from its investigation of benzene in acne products containing benzoyl peroxide. In light of these findings, the American Academy of Dermatology updated its statement on benzoyl peroxide in personal care products.